These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2887616)

  • 21. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of famotidine on oxidative drug metabolism.
    Somerville KW; Kitchingman GA; Langman MJ
    Eur J Clin Pharmacol; 1986; 30(3):279-81. PubMed ID: 2874031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of famotidine on cat gastric secretion.
    Coruzzi G; Bertaccini G; Noci MT; Dobrilla G
    Agents Actions; 1986 Nov; 19(3-4):188-93. PubMed ID: 2881456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
    Scarpignato C; Tramacere R; Zappia L
    Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies.
    Yeh KC; Chremos AN; Lin JH; Constanzer ML; Kanovsky SM; Hucker HB; Antonello J; Vlasses P; Ryan JR; Williams RL
    Biopharm Drug Dispos; 1987; 8(6):549-60. PubMed ID: 2892544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T; Ohta H; Maekawa M; Yamamoto Y; Ishida Y; Hara H; Nakamura S; Ushiogi Y; Kawabata M; Hashimoto N
    Eur J Clin Pharmacol; 1985; 28(3):327-31. PubMed ID: 2861096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of diazepam with famotidine and cimetidine, two H2-receptor antagonists.
    Locniskar A; Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    J Clin Pharmacol; 1986 Apr; 26(4):299-303. PubMed ID: 2871051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers.
    Lin JH; Chremos AN; Chiou R; Yeh KC; Williams R
    Br J Clin Pharmacol; 1987 Nov; 24(5):669-72. PubMed ID: 2893637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gastric acid suppressants on human gastric motility.
    Parkman HP; Urbain JL; Knight LC; Brown KL; Trate DM; Miller MA; Maurer AH; Fisher RS
    Gut; 1998 Feb; 42(2):243-50. PubMed ID: 9536950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
    Takagi T; Takeda M; Maeno H
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of famotidine.
    Echizen H; Ishizaki T
    Clin Pharmacokinet; 1991 Sep; 21(3):178-94. PubMed ID: 1764869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human acid secretion during daily administration of H2-blockers].
    Müller P; Simon B; Dammann HG; Feurle G; Lichtwald K; Schmidt-Gayk H
    Schweiz Med Wochenschr; 1984 May; 114(19):667-71. PubMed ID: 6330886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.